Stay updated on Pediatric HIV Triple Therapy Clinical Trial
Sign up to get notified when there's something new on the Pediatric HIV Triple Therapy Clinical Trial page.

Latest updates to the Pediatric HIV Triple Therapy Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study record page now returns a 403 Forbidden error, replacing the study details with an error page. A Home link is shown in the header.SummaryDifference23%

- Check18 days agoChange DetectedA new publication reference by McKenna et al. is added to the Publications section (Growth Outcomes After 48 Weeks of Dolutegravir in Children and Adolescents with HIV-1 in IMPAACT); the page revision is updated to v3.7.0.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page revision moved from v3.6.5 to v3.6.6, indicating a newer revision of the page. This update does not change the study content visible to users.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, representing a small system update with no visible changes to study information or page content.SummaryDifference0.0%

- Check75 days agoChange DetectedThe revision label on the page changed from v3.6.3 to v3.6.4, indicating a new revision of the page.SummaryDifference0.0%

- Check97 days agoChange DetectedRevision updated from v3.6.0 to v3.6.3 on the page, indicating a new build/patch of the site.SummaryDifference0.0%

Stay in the know with updates to Pediatric HIV Triple Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric HIV Triple Therapy Clinical Trial page.